Fast-Track Project Delivery Model
Challenge from the Client
A global manufacturer and distributor of the Ebola vaccine required an expansion of their existing facility from an annual output of 20 million liquid-filled vials and 7.5 million freeze-dried vials to 40 million liquid-filled vials and 8 million freeze-dried vials. This project extended our clients current business scope of operation to bring fill/finish operations in-house where it was subcontracted before. The project’s aggressive timeline had design to OQ being finished in 18 months.
Our Approach & Solution
The key to coordinating a fast-track project delivery is the level of ‘design assist’ received from good quality trade partners being on board at an early stage with a good level of in-house design skills.
The traditional approach saw the preliminary design reviewed and agreed upon with the client prior to progressing into the detail design stage. It is only after this stage that discussions with trade partners would commence. This would be the perfect model if there were no time pressures on a project & there was a strong emphasis on maintaining the project budget. Fixed price contracts could be implemented as the risk to change would be low.
Fast-track incorporates a more collaborative and autonomous approach, with subcontractors brought onto the project after the preliminary design to support a design-assist approach between contactors, clients & designers. Every project has elements of change due to the collaborative nature, however project managers need to work together to manage the “nice to have” to “necessity.” This approach lends itself to a time & material contract but requires strong management to maintain budget control, and agreed contingency levels in case of unforeseen changes.
The benefits of removing the bidding phase and team selection enabled the final design to be implemented by the subcontractors with IPS designers taking on a review and approval role. The IPS design team would only step in if the skill-set was not available within the subcontractor.
The construction phase started earlier as the subcontractors were involved during the design-assist phase, reducing the level of technical queries (TQ) as well as developing the design with a preferred buildability method. The design-assist method eliminated risk to the construction program by identifying long lead equipment items and ensured they are procured to meet the early construction phase start.
The Results
- Successful completion of project, from design to OQ in 18 months
- Autonomous design-assist approach
- Early engagement with subcontractors being part of the design process and greater project knowledge
- Reduced site technical queries
- Earlier start to the construction phase with the fastest project delivery
Related Molecules
Mobile Modular Vaccine Facility
Read MoreDeliver a modular vaccine facility capable of being relocated anywhere in the world with minimal host facility requirements.
Delivering a New Building with Two Project Teams
Read MoreProvided a client and building tenant with construction management services for the interior fit-out of a new 50,000sf pharmaceutical testing facility while a separate vendor constructs the core & shell for the landlord.
Clinical Aseptic Spray Drying Facility Project
Read MoreIPS utilized the Inceptioneering process and expertise in aseptic spray drying technology for manufacturing APIs for formulation and filling.
Replacement Powder Mill for Pharmaceutical Client
Read MoreAfter a previous remediation attempts from other consultants failed, IPS was brought in to solve our client’s excess temperature problems in their new milling equipment.
Potent Processing on Antiquated Equipment
Read MoreIPS experts provided the latest technical solutions to retrofit a facility to improve manufacturing processes.
Modular Design, Construction and Installation of QC Labs
Read MoreA copy/paste modular build from the UK to Spain that overcame hurdles from the UK’s decision to leave the European Union.
Design of an Award-Winning, Fully Integrated Dual Sterile Filtration Unit, With In-situ Integrity Testing and Elimination of Contamination Routes
Read MoreIPS experts designed a filter skid system to eliminate contamination risks related to manual operations.
Innovative Commercial-Scale Parenteral Fill/Finish Facility
Read MoreUsing Facility of the Future design principles, IPS designed a world-class, flexible, 490,000sf. facility.
3D Modelling and Laser Scanning
Read More3D laser scanning used to coordinate and design a new PTW generation skid and pipework connections within an existing operating facility.
Next Generation Propellant Technology for Pharmaceutical MDI Applications
Read MoreIPS provided technical and site master planning expertise enabling new commercial opportunities within the MDI market sector.
Antibody Drug Conjugation Commercial Manufacturing
Read MoreApplied first class design tools and industry specific experiences to develop a greenfield site for commercial ADC manufacturing.
Mammalian Cell Culture to COVID-19 Vaccine Adjuvant in 3 weeks
Read MoreSoon after the COVID-19 outbreak, our client's direction shifted quickly from a mammalian cell culture facility to a COVID-19 vaccine adjuvant production facility.
Annex 1 - The Brave New World of Aseptic Regulatory Compliance
Read MoreAfter six years in review, the final emergence of Annex 1 in August 2022 has either been a consolidation of accepted practice and wisdom, or a rude awakening for many!
Gene Therapy Facility
Read MoreOur client needed an efficient design for their gene biologics plant within an existing building with limited space for air handlers and mechanical equipment.
Large-Scale Bulk Manufacturing Facility
Read MoreIPS built a new greenfield facility in Ireland for bulk biologics manufacturing with single-use technology under an extremely aggressive timeline.
Single-Use Mammalian Cell Culture Facility - Vial to Vial
Read MoreOur challenge was to design a biologics manufacturing launch facility within an existing shell & office building.
Detailed Process Piping
Read MoreSupporting a client’s dynamic business requirements to produce a near-fabrication-level model to reduce schedule time.
Water For Injection (WFI) Generation System Design for a Global CMO Biotechnology Facility for the Manufacture of mAb/Recombinant Protein
Read MoreBiotech CMO client needed an n+1 redundant system to handle increased WFI demand, while reducing operating costs.
Commercial Manufacturing of Autologous Muscle Derived Cell (AMDC) products
Read MoreApplying industry-leading knowledge and expertise to support CGMP-compliant manufacturing process scale-up.
Clinical Phage Production - Design/Build/Qualify
Read MoreA start-up biotech company needed to generate phase 1 and phase 2 clinical material for a phage-based therapy on an aggressive timeline and tight budget.
Largest Single-use Based mAb Facility in the World
Read MoreOur CMO client wanted to do something radically different by creating a multiproduct, multiscale mAb facility that could flex upstream capacity in 2000L intervals.
